approval
saveBALVERSA (ERDAFITINIB) — FDA approval
community read0 votes
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalBALVERSA (ERDAFITINIB) — FDA approvalOct 17, 2025 · 354d ago
- approvalBALVERSA (ERDAFITINIB) — FDA approvalOct 9, 2024 · 727d ago
- approvalBALVERSA (ERDAFITINIB) — FDA approvalJan 19, 2024 · 991d ago
- approvalBALVERSA (ERDAFITINIB) — FDA approvalJan 19, 2024 · 991d ago
- approvalBALVERSA (ERDAFITINIB) — FDA approvalMar 20, 2023 · 1296d ago
- approvalBALVERSA (ERDAFITINIB) — FDA approvalJan 11, 2023 · 1364d ago
- approvalBALVERSA (ERDAFITINIB) — FDA approvalApr 27, 2022 · 1623d ago
- approvalBALVERSA (ERDAFITINIB) — FDA approvalApr 27, 2022 · 1623d ago
same company · ±60 days · 6
- approvalerdafitinib: BALVERSA (ERDAFITINIB) — FDA approvalJan 19, 2024
- approvalerdafitinib: BALVERSA (ERDAFITINIB) — FDA approvalJan 19, 2024
- approvalapalutamide: ERLEADA (APALUTAMIDE) — FDA approvalDec 19, 2023
- approvaltalquetamab: TALVEY (TALQUETAMAB-TGVS) — FDA approvalFeb 20, 2024
- approvalteclistamab: TECVAYLI (TECLISTAMAB-CQYV) — FDA approvalFeb 20, 2024
- approvalamivantamab: RYBREVANT (AMIVANTAMAB-VMJW) — FDA approvalMar 1, 2024
comments(0)
5-min edit window · permanent after that